Median Technologies (XPAR:ALMDT) 5-Year EBITDA Growth Rate : -6.60% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Median Technologies 5-Year EBITDA Growth Rate?

Median Technologies's EBITDA per Share for the six months ended in Dec. 2023 was €-0.52.

During the past 3 years, the average EBITDA Per Share Growth Rate was -5.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -6.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Median Technologies was 19.00% per year. The lowest was -47.50% per year. And the median was -0.65% per year.

Competitive Comparison of Median Technologies's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Median Technologies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Median Technologies's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Median Technologies's 5-Year EBITDA Growth Rate falls into.

Median Technologies 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Median Technologies (XPAR:ALMDT) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Median Technologies 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Median Technologies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

4ZG:Germany

Address

1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560

Website

https://www.mediantechnologies.com

Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies Headlines

No Headlines